That’s because ocrelizumab temporarily weakens your immune system. Your doctor will watch you for signs of infection after you get the medicine. They'll also ask you to let them know if you ...

The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus) treats relapsing forms of MS, including: Clinically isolated syndrome Relapsing-remitting MS Active secondary progressive MS in ...

The rates were higher in primary progressive MS than in relapsing MS. Patients with multiple sclerosis (MS) have a manageable infection risk profile through long-term treatment with ocrelizumab, ...

A screenshot of the ABC News-hosted presidential debate between Kamala Harris and Donald Trump in September 2024. Picture: Youtube screenshot of Wall Street Journal debate stream Half of the world ...

A new study, commissioned by the Multiple Sclerosis Society of New Zealand (MSNZ), analysed the cost-effectiveness of Ocrelizumab - which got funded as a treatment for primary progressive multiple ...

The medicine, called ocrelizumab, is normally given as an infusion through a vein - a process that can take up to four hours in hospital. The new way to give the drug will help free up patients ...

Of the three types of MS, PPMS is considered the rarest, affecting 10% of people living with MS. As with other forms of MS, ...

Infusion therapy is often used to deliver certain disease-modifying therapies (DMTs) to patients with MS. DMTs suppress ...